TY - JOUR
T1 - Temporal Trends in Use of Complementary Therapies Among Patients With Cardiovascular Disorders
AU - Prasad, Kavita
AU - Prasad, Abhiram
AU - George, Merit
AU - Sandhu, Gurpreet S.
AU - Inojosa, Jose R.Medina
AU - Bhagra, Anjali
AU - Mahapatra, Saswati
AU - Petterson, Tanya M.
AU - Lackore, Kandace A.
AU - Croghan, Ivana T.
AU - Bauer, Brent A.
AU - Wahner-Roedler, Dietlind L.
N1 - Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2022/3/15
Y1 - 2022/3/15
N2 - This study aimed to evaluate the use and frequency of complementary and integrative medicine (CIM) therapies in an outpatient cohort with cardiovascular disease (CVD) and compare trends over time. This cross-sectional point-of-care prospective study assessed patients attending a cardiology outpatient clinic. As in our 2009 cohort, data were collected with a 17-question survey on demographic characteristics, CVD history, current use and future interest in CIM. In total, 964 patients completed the survey. CIM use continues to be high (2009 vs 2018, 83.4% vs 81.8%) (p = 0.34), with dietary supplements the most common therapy (75% in both studies). We observed increased use of mind-body therapies (28.5% vs 23.9%, p = 0.02), especially meditation, yoga, and tai chi. Of the patients receiving CIM therapies, 41.9% reported using CIM for heart-related symptoms. Relaxation, stress management, and meditation were the top three mind-body therapies for CVD-related symptoms in both cohorts. Reporting of CIM use to clinicians is low (15%) and interest on future use is high (47%). In conclusion, CIM is highly used in cardiology patients—4 of 10 patients use CIM for CVD-related symptoms. Most take dietary supplements, with an increased use of mind-body therapies. Our data highlight the importance of documenting CIM use in practice and the need for research to document efficacy.
AB - This study aimed to evaluate the use and frequency of complementary and integrative medicine (CIM) therapies in an outpatient cohort with cardiovascular disease (CVD) and compare trends over time. This cross-sectional point-of-care prospective study assessed patients attending a cardiology outpatient clinic. As in our 2009 cohort, data were collected with a 17-question survey on demographic characteristics, CVD history, current use and future interest in CIM. In total, 964 patients completed the survey. CIM use continues to be high (2009 vs 2018, 83.4% vs 81.8%) (p = 0.34), with dietary supplements the most common therapy (75% in both studies). We observed increased use of mind-body therapies (28.5% vs 23.9%, p = 0.02), especially meditation, yoga, and tai chi. Of the patients receiving CIM therapies, 41.9% reported using CIM for heart-related symptoms. Relaxation, stress management, and meditation were the top three mind-body therapies for CVD-related symptoms in both cohorts. Reporting of CIM use to clinicians is low (15%) and interest on future use is high (47%). In conclusion, CIM is highly used in cardiology patients—4 of 10 patients use CIM for CVD-related symptoms. Most take dietary supplements, with an increased use of mind-body therapies. Our data highlight the importance of documenting CIM use in practice and the need for research to document efficacy.
UR - http://www.scopus.com/inward/record.url?scp=85122623794&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85122623794&partnerID=8YFLogxK
U2 - 10.1016/j.amjcard.2021.11.050
DO - 10.1016/j.amjcard.2021.11.050
M3 - Article
C2 - 35031110
AN - SCOPUS:85122623794
SN - 0002-9149
VL - 167
SP - 118
EP - 124
JO - American Journal of Cardiology
JF - American Journal of Cardiology
ER -